Free Newsletter
$2.5B in outsourcing headed India's way
Subcontinent rising: A new report on India's pharmaceuticals industry predicts it will take over about $2.5 billion in drugmakers' outsourcing by 2012. As companies in the EU and U.S. look for lower-cost manufacturing and R&D, India will get an influx of new work, according to the report from Zinnov Management Consulting.
The country has certainly done a lot to encourage that growth. Besides a rich talent pool and a number of pharma-educational institutes, the Indian government has also started offering tax incentives to drugmakers and set up some necessary legal infrastructure, the report says. "India has the potential to become one of the key global pharmaceutical players and also become the backbone of off-shored services in Pharmaceuticals," Zinnov's CEO said.
- read the story at India Infoline
Related Articles:
India's biopharma surges on outsourcing boom
Outsourcing: Good for what ails pharma
Pharma outsourcing continues to swell
Forecast: BioPharma outsourcing will grow '08
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





